AMCX
AMC Networks Inc.
AMCX's outlook is improving, though it still trails on the overall score.
META
Meta Platforms, Inc.
META has the edge over AMCX overall, supported by stronger valuation and lower modeled downside.
AMCX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Weak |
AMCX's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
AMCX PE Valuation
AMCX has no meaningful PE right now: it lost money over the past year.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
AMCX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
AMCX has the edge over META on the outlook, with more favorable profitability expectations.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
AMCX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.22 | — |
| Q3 2026 | -$3.04 | +$0.56 |
| Q2 2026 | -$0.53 | +$3.69 |
| Q1 2026 | $0.89 | +$6.68 |
| Q4 2025 | $1.66 | +$6.76 |
| Q3 2025 | -$3.60 | -671% |
| Q2 2025 | -$4.22 | -422% |
| Q1 2025 | -$5.79 | -262% |
| Q4 2024 | -$5.10 | -204% |
AMCX lost $3.04 per share over the past year, a smaller loss than the year before, but its loss has widened in each of the last three quarters.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over AMCX on earnings quality, reporting a profit while its opponent remains loss making.
AMCX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $566.1M | +0.8% |
| Q2 2026 | $547.5M | -8.8% |
| Q1 2026 | $542.1M | -2.4% |
| Q4 2025 | $594.8M | -0.8% |
| Q3 2025 | $561.7M | -6.3% |
| Q2 2025 | $600M | -4.1% |
| Q1 2025 | $555.2M | -6.9% |
| Q4 2024 | $599.3M | -12% |
AMCX's revenue fell from its 2022 peak and has held roughly level since: $566M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.3% | -17 points |
| Q2 2026 | 2.9% | -7.8 points |
| Q1 2026 | 5.8% | -5.8 points |
| Q4 2025 | -8.6% | +34 points |
| Q3 2025 | 9.9% | -5.7 points |
| Q2 2025 | 11% | +9 points |
| Q1 2025 | 12% | -6.9 points |
| Q4 2024 | -42% | -41 points |
AMCX's operating margin was −7.3% last quarter, down 17 points from the same quarter a year ago.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over AMCX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over AMCX on profitability, with a higher operating margin.
AMCX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$52.4M | -225% |
| Q2 2026 | $43.3M | -55% |
| Q1 2026 | $64.8M | -31% |
| Q4 2025 | $40.4M | +7.6% |
| Q3 2025 | $42M | -22% |
| Q2 2025 | $95.7M | +0.6% |
| Q1 2025 | $94.2M | -35% |
| Q4 2024 | $37.6M | -43% |
AMCX usually generates cash, though not every quarter: the latest was −$52M, but it generated $96M over the past year.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META has the edge over AMCX on cash flow, with more consistent year-over-year improvement.
AMCX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.7% | -1.2M shares |
| 1 year | -26% | -14.4M shares |
| 3 years | -4.7% | -2.1M shares |
| 5 years | -3.5% | -1.5M shares |
| Available history | -27% | -15.2M shares |
AMCX has the edge over META on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $7.6M |
| Q3 2025 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $253.8M |
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
AMCX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 32.2x | High |
| Q2 2026 | 8.7x | High |
| Q1 2026 | 6.1x | High |
| Q4 2025 | 5.5x | High |
| Q3 2025 | 56.4x | High |
| Q2 2025 | 21.9x | High |
| Q1 2025 | 193.8x | High |
| Q4 2024 | 26.6x | High |
AMCX's net debt is more than 20 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META has the edge over AMCX on leverage, with a lower net debt burden relative to earnings.
AMCX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.3 | Neutral |
| Stochastic | 21.8 | Neutral |
AMCX's weekly RSI is 45 (neutral) and its Stochastic is 22 (neutral).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
AMCX PE vs Communication Services Sector
| Metric | AMCX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
AMCX has no meaningful PE right now: it lost money over the past year.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
AMCX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.88 | 5.6% below |
| 20 week MA | $10.8 | 14% below |
| 50 week MA | $9.45 | 1.3% below |
| 100 week MA | $8.44 | 11% above |
| 200 week MA | $10.9 | 15% below |
AMCX's trend is mixed: it's above one of its five weekly moving averages, and 15% below its 200-week average.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
AMCX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $39.5 | $32.9 | -17% |
| 2021 | $32.9 | $35.9 | +9.1% |
| 2022 | $35.9 | $15.6 | -57% |
| 2023 | $15.6 | $18.8 | +21% |
| 2024 | $18.8 | $9.42 | -50% |
| 2025 | $9.42 | $9.80 | +4% |
| 2026 YTD | $9.80 | $9.33 | -4.8% |
AMCX has the edge over META on returns for 2026, with the stronger performance.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META's yearly returns have swung widely, from +200% in 2023 to −65% in 2022. It's down 6% so far in 2026.